Clinical efficacy and safety of guselkumab maintenance therapy in patients with moderately to severely active Crohn's Disease: Week 48 analyses from the phase 2 GALAXI 1 study

Category Primary study
JournalJournal of Crohn's and Colitis
Year 2022
This article has no abstract
Epistemonikos ID: 3dd400b766aef6f09300ef5c6f42c29b668dfa17
First added on: Feb 13, 2025